Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Sebastian Konzok (Hannover, Germany), Sebastian Konzok, Susann Dehmel, Peter Braubach, Danny Jonigk, Olaf Pfennig, Hans-Gerd Fieguth, Armin Braun, Katherina Sewald. Anti-cancer effects of bevacizumab and cisplatin on cancer cell invaded human ex-vivo lung tissue. Eur Respir J 2016; 48: Suppl. 60, 6022

Member's Comments

No comment yet.

Related content which might interest you: Effect of 17-oxo-DHA alone and in combination with gemcitabine on lung cancer cell growth Source: International Congress 2016 – Late-breaking translational research in lung cancer Year: 2016 Dihydroartemisinin combined with cisplatinum induced apoptosis and related mechanism research in human lung adenocarcinoma H1299 cells Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Antitumor efficacy of the double suicide genesin lung cancer cells Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 CD33+CD14-CD11b+CD66b+CD15+VEGFR-1hi myeloid derived suppressor cells and their clinical relevance in non-small cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Reduction of peak oxygen consumption in patients with non-small cell lung cancer treated with neoadjuvant chemotherapy Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Combination of oral and parenteral vinorelbine with cisplatin or carboplatin in adjuvant chemotherapy of nonsmall cell lung cancer - SWITCH study Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Changes in lymphocyte subgroups of non-small cell lung cancer patients during chemotherapy Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Cox-2 inhibitors in the treatment of small cell lung cancer patients Source: International Congress 2015 – Advances in the therapy of lung cancer Year: 2015 The active compound of garlic to treat non-small cell lung cancer: in vitro studies Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Abnormal abundance of senescent fibroblasts in the tumor stroma of non-small cell lung cancer patients Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Clinical outcome of S-1 monotherapy in patients with advanced non-small cell lung cancer after treatment of pemetrexed Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 Loss of heterozygosity of PTEN in patients with non-small cell lung cancer treated and not treated with neoadjuvant chemotherapy Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013 Single agent gemcitabine or docetaxel in the second-line therapy for patients with non-small cell lung cancer previously treated with platin-based chemotherapy Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Screening for intracerebral metastasis in radically treated non-small cell lung cancer patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Simultaneous EGFR and VEGF alterations in non-small cell lung carcinoma based on tissue microarrays Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Encapsulation of vinorelbine in polymeric nanoparticles improves efficacy in cancer cells and reduces inflammation in non-cancer cells Source: International Congress 2016 – Late-breaking translational research in lung cancer Year: 2016 RBM5 overexpression reverses acquired resistance to gefitinib in PC9/AB2 NSCLC cells Source: International Congress 2016 – Late-breaking translational research in lung cancer Year: 2016 Management of extensive disease-small cell lung cancer Source: Eur Respir Mon; 2009: 44: 310–317 Year: 2009 Functional impairment of NK cells in non-small-cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014